Molecular Evolution of Human Parainfluenza Virus Type 2 Based on Hemagglutinin-Neuraminidase Gene
Yi Feng, Wenbo Xu(Shenyang Institute of Automation), Liwei Sun(Chinese Center For Disease Control and Prevention), Yixin Ji(National Institute for Viral Disease Control and Prevention), Zhen Zhu(Center for Disease Control), Hui Zhang(Edinburgh Napier University), Feng Zhang(Affiliated Hospital of North Sichuan Medical College), Ying Liu(National Institute for Viral Disease Control and Prevention), Yan Zhang(Memorial Sloan Kettering Cancer Center), Shanshan Zhou(National Institute for Viral Disease Control and Prevention), Jin Xu(Henan Provincial Center for Disease Control and Prevention), Hongmei Xu(Biology of Infection), Jie Jiang(Taiwan Centers for Disease Control), Guangyue Han, Wenyang Wang(National Center for Nanoscience and Technology), Naiying Mao(Centers for Disease Control and Prevention)
Cited by 7
Related Papers
A Novel Coronavirus from Patients with Pneumonia in China, 2019
|New England Journal of Medicine|2020|30.5k
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
|The Lancet|2020|12.6k
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
|Nature|2020|1.2k
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
|Cell|2020|802
Genetic evidence supports demic diffusion of Han culture
|Nature|2004|482